Cell type specific expression of secretory TFF peptides: Colocalization with mucins and synthesis in the brain

International Review of Cytology

Volumn 213, Issue , 2002, Pages 147-181

  Hoffmann, Werner ^a   Jagla, Wolfgang ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Cell migration; Goblet cell; Inflammation; Mucins; Pituitary; TFF domain; Ulcer

Indexed keywords

OXYTOCIN RECEPTOR; SECRETORY PROTEIN; TFF PEPTIDE; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; CELL MIGRATION; CELL STRUCTURE; CELL SURFACE; CELL TYPE; CHRONIC INFLAMMATION; EPITHELIUM CELL; GOBLET CELL; HYPOTHALAMUS; NEUROHYPOPHYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; TISSUE REGENERATION; ULCER; XENOPUS LAEVIS;

LOTUS; MAMMALIA; XENOPUS LAEVIS;

EID: 0036158092     PISSN: 00747696     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7696(02)13014-2     Document Type: Chapter

References (225)

1. The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland
2. Transcription factor GATA-6 activates expression of gastroprotective trefoil genes TFF1 and TFF2
3. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach
4. Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization
5. Aspirin promotes TFF2 gene activation in human gastric cancer cell lines
6. Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats
7. Expression of the oestrogen responsive protein pS2 in human breast cancer
8. The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues
9. Factors regulating pS2-reporter gene expression in MCF-7 breast cancer cell line
10. 5′-flanking motifs control cell-specific expression of trefoil factor genes (TFF)
11. Hepatocyte nuclear factor 3 (winged helix domain) activates trefoil factor gene TFF1 through a binding motif adjacent to the TATAA box
12. Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence
13. A trefoil domain in the major rabbit zona pellucida protein
14. Structure of Xenopus laevis TFF-gene xP4.1, differentially expressed to its duplicated homolog xP4.2
15. Effects of TFF-peptides on epithelial cell migration and intracellular signaling in vitro
16. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7
17. The trefoil gene maps to mouse chromosome 17
18. Estrogen receptor α and β expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats
19. 1H NMR-based determination of the secondary structure of procine pancreatic spasmolytic polypeptide: One of a new family of "trefoil" motif containing cell growth factors
20. Solution structure of a trefoilmotif-containing cell growth factor, porcine spasmolytic protein
21. Regulation of cathepsin-D and pS2 gene expression by growth factors in MCF7 human breast cancer cells
22. Homodimerization and heterooligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58
23. Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer
24. Transcription factor NF-κB signals antianoikic function of trefoil factor 3 on intestinal epithelial cells
25. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat
26. Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by in situ hybridization
27. Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers
28. The gene encoding mouse intestinal trefoil factor: Structural organization, partial sequence analysis and mapping to murine chromosome 17q
29. The gene encoding human intestinal trefoil factor (TFF3) is located on chromosome 21q22.3 clustered with other members of the trefoil peptide family
30. Differential RNA expression of the pS2 gene in the human benign and malignant prostatic tissue
31. Oral human spasmolytic polypeptide protects against aspirin-induced gasric injury in rats
32. The trefoil peptides TFF2 and TFF3 are expressed in rat lymphoid tissues and participate in the immune response
33. Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors
34. Trefoil factor expression in normal and diseased human salivary glands
35. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway
36. Trefoil factor family domain peptides in the human respiratory tract
37. pS2 expression induced by American ginseng in MCF-7 breast cancer cells
38. Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor α
39. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells
40. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells
41. Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells
42. In vivo restitution of airway epithelium
43. Trefoil peptides are early markers of gastrointestinal maturation in the rat
44. Receptor binding of pancreatic spasmolytic polypeptide (PSP) in rat intestinal mucosal cell membranes inhibits the adenylate cyclase activity
45. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis
46. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia
47. Pancreatic spasmolytic polypeptide: Crystallization, circular dichroism analysis, and preliminary X-ray diffraction studies
48. Pancreatic spasmolytic polypeptide: First three-dimensional structure of a member of the mammalian trefoil family of peptides
49. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines
50. Identification of a motif within the 5′ regulatory region of pS2 which is responsible for AP-1 binding and TCDD-mediated suppression
51. Mucin genes expressed by the ocular surface epithelium
52. Trefoil peptides promote restitution of wounded corneal epithelial cells
53. Crystallization and preliminary X-ray diffraction studies of pancreatic spasmolytic polypeptide
54. Human trefoil peptides: Genomic structure in 21q22.3 and coordinated expression
55. Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype
56. Isolation of a cDNA probe for a human jejunal brush-border hydrolase, sucrase-isomaltase, and assignment of the gene locus to chromosome 3
57. Tanycytes in the human median eminence contain intestinal trefoil factor (hITF)
58. The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in "gastric metaplasia" of the proximal duodenum: Implications for the nature of "gastric metaplasia:"
59. Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach
60. Hyperplastic polyps: A cell lineage which both synthesizes and secretes trefoil-peptides and has phenotypic similarity with the ulcer-associated cell lineage
61. Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: Delineation of epithelial phenotype
62. The mucous neck cell in the human gastric corpus: A distinctive, functional cell lineage
63. Cloning and characterization of zona pellucida genes and cDNAs from a variety of mammalian species: The ZPA, ZPB and ZPC gene families
64. The DNA sequence of human chromosome 21
65. xP1 and xP4: P-domain peptides expressed in Xenopus laevis stomach mucosa
66. P-domains as shuffled cysteine-rich modules in integumentary mucin C.1 (FIM-C.1) from Xenopus laevis
67. Expression of spasmolysin (FIM-A.1): An integumentary mucin from Xenopus laevis
68. xP2, a new member of the P-domain peptide family of potential growth factors, is synthesized in Xenopus laevis skin
69. hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus
70. Estimation of serum level of pS2 protein in patients with lung adenocarcinoma
71. Expression of pS2 gene in human breast cancer cell line MCF-7 is controlled by retinoic acid
72. Cytokine regulation of pS2 gene expression in mouse astrocytes
73. pS2 gene especially expressed in the late G1/s phase of mouse astrocytes
74. Expression of pS2 gene in rat brain
75. Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression
76. Primary structure and processing of lysosomal α-glucosidase; Homology with the intestinal sucrase-isomaltase complex
77. A new repetitive protein from Xenopus laevis skin highly homologous to pancreatic spasmolytic polypeptide
78. The P-domain or trefoil motif: A role in renewal and pathology of mucous epithelia?
79. Biosynthesis of frog skin mucins: Cysteine-rich shuffled modules, polydispersities and genetic polymorphism
80. Biosynthesis and molecular architecture of gel-forming mucins: Implications from an amphibian model system
81. Molecular medicine of TFF-peptides: From gut to brain
82. Different mucins are produced by the surface epithelium and the submucosa in human trachea: Identification of MUC5AC as a major mucin from the goblet cells
83. Identification of the true human orthologue of the mouse Zp1 gene: Evidence for greater complexity in the mammalian zona pellucida?
84. cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis
85. Goblet-cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of complex series of positive and negative regulatory elements
86. A silencer inhibitor confers specific expression of intestinal trefoil factor in gobletlike cell lines
87. Differential expression of the TFF-peptides xP1 and xP4 in the gastrointestinal tract of Xenopus laevis
88. Secretion of TFF-peptides by human salivary glands
89. Localization of TFF3 peptide to porcine conjunctival goblet cells
90. Co-localization of TFF3 peptide and oxytocin in the human hypothalamus
91. Sequence of the pS2 mRNA induced by estrogen in human breast cancer cell line MCF-7
92. Spasmolytic polypeptide: A trefoil peptide secreted by rat gastric mucous cells
93. Structure of the human oestrogen-responsive gene pS2
94. Similarities of integumentary mucin B.1 from Xenopus laevis and prepro-von Willebrand factor at their amino-terminal regions
95. Pancreatic spasmolytic polypeptide (PSP): I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas
96. Estrogenic effects of extracts from cabbage, fermented cabbage, and acidified brussels sprouts on growth and gene expression of estrogen-dependent human breast cancer (MCF-7) cells
97. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures
98. A novel 25 bp tandem repeat within the human trefoil peptide gene TFF2 in 21q22.3: Polymorphism and mammalian evolution
99. Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers
100. Estrogen-inducible pS2 protein is not the key regulatory component in the proliferation of human breast cancer cells (MCF-7)
101. Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein
102. Distinct pathways of cell migration and antiapoptotic response to epithelial injury: Structure-function analysis of human intestinal trefoil factor
103. Regulation of cell motility by mitogen-activated protein kinase
104. Role of spasmolytic polypeptide in healing of stress-induced gastric lesions in rats
105. Activation of genes for spasmolytic peptide, transforming growth factor alpha and for cyclooxygenase (COX)-1 and COX-2 during gastric adaptation to aspirin damage in rats
106. Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus
107. Epithelial restitution in the gastrointestinal tract
108. Trefoil factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells
109. Cross-coupling of AP-1 and intracellular hormone receptors
110. Secretory peptides TFF1 and TFF3 synthesized in human conjunctival goblet cells
111. The mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression
112. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein
113. High-resolution structure of human intestinal trefoil factor and functional insights from detailed structural comparisons with the other members of the trefoil family of mammalian cell motility factors
114. Expression of intestinal trefoil factor in developing rat intestine
115. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa
116. Osmotic changes and ethanol modify TFF gene expression in gastrointestinal cell lines
117. Dimerization of human pS2 (TFF1) plays a key role in its protective/healing effects
118. Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice
119. Genomic sequencing indicates a correlation between DNA hypomethylation in the 5′ region of the pS2 gene and its expression in human breast cancer cell lines
120. Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers
121. The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein
122. Structure and expression of murine intestinal trefoil factor: High evolutionary conservation and postnatal expression
123. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
124. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line
125. Quantitative analysis reveals differential expression of mucin (MUC2) and intestinal trefoil factor mRNAs along the longitudinal axis of rat intestine
126. Expression of human intestinal trefoil factor in malignant cells and its regulation by oestrogen in breast cancer cells
127. Trefoil proteins: Their role in normal and malignant cells
128. The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach
129. Migration of IEC-6 cells: A model for mucosal healing
130. Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility
131. Topical and intravenous administration of trefoil factors protect the gastric mucosa from ethanol-induced injury in the rat
132. Effect of basic fibroblast growth factor on synthesis/secretion of pS2 protein by human breast cancer cells (MCF-7)
133. Estimation of pS2 protein level in human body fluids by a sensitive two-site enzyme immunoassay
134. Secretion of the trefoil factor TFF3 from the isolated vascularly perfused rat colon
135. The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach
136. Human small intestinal maltase-glucoamylase cDNA cloning: Homology to sucrase-isomaltase
137. Differential expression of human high-molecular-weight salivary mucin (MG1) and low-molecular-weight salivary mucin (MG2)
138. Identification of a major human high molecular weight salivary mucin (MG1) as tracheobronchial mucin MUC5B
139. Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation
140. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein
141. Trefoil factor family-peptides promote migration of human bronchial epithelial cells: Synergistic effect with epidermal growth factor
142. Trefoil peptide expression and secretion is regulated by neuropeptides and acetylcholine
143. Identification of a goblet cell-specific enhancer element in the rat intestinal trefoil factor gene promoter bound by a goblet cell nuclear protein
144. Differential expression of human spasmolytic polypeptide (trefoil factor family-2) in pancreatic carcinomas, and mucin-producing tumors of the pancreas
145. Trefoil factor family (TFF)-domain peptides in the mouse: Embryonic gastrointestinal expression and wounding response
146. Somatic mutations of the trefoil factor family 1 gene in gastric cancer
147. Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers
148. Introns and exons
149. Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa
150. Structure of porcine pancreatic spasmolytic polypeptide at 1.95 A resolution
151. Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry
152. Differential induction of pS2 and cathepsin D mRNAs by structurally altered estrogens
153. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration
154. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract
155. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage
156. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion
157. NMR-based structural studies of the pNR-2/pS2 single domain trefoil peptide: Similarities to porcine spasmolytic peptide and evidence for a monomeric structure
158. High resolution solution structure of human pNR-2/pS2: A single trefoil motif protein
159. Identification of distant homologues of fibroblast growth factors suggests a common ancestor for all β-trefoil proteins
160. Distribution and metabolism of intravenously administered trefoil factor 2/porcine spasmolytic polypeptide in the rat
161. Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat
162. Intestinal trefoil factor (TFF3) and pS2 (TFF1), but not spasmolytic polypeptide (TFF2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium
163. Molecular and cellular analysis of rP1.B in the rat hypothalamus: In situ hybridization and immunohistochemistry of a new P-domain neuropeptide
164. Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: Evidence for a novel neuropeptide
165. Neuronal nitric oxide synthase (NOS) regulates the expression of inducible NOS in rat small intestine via modulation of nuclear factor kappa B
166. Immunohistochemical localization of pancreatic spasmolytic polypeptide (PSP) in the pig
167. The pS2/TFF1 trefoil factor, from basic research to clinical applications
168. Mouse trefoil factor genes: Genomic organization, sequences and methylation analyses
169. The pS2 gene, mRNA, and protein: A potential marker for human breast cancer
170. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2
171. Breast cancer-associated pS2 protein: Synthesis and secretion by normal stomach mucosa
172. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract
173. Activation of cellular invasion by trefoil peptides and src is mediated by cycloxygenase- and thromboxane A2 receptor-dependent signaling pathways
174. Revised amino acid sequence of pancreatic spasmolytic polypeptide exhibits greater similarity with an inducible pS2 peptide found in a human breast cancer cell line
175. Elevation of TFF1 gene expression during healing of gastric ulcer at non-ulcerated sites in the stomach: Semiquantification using the single tube method of polymerase chain reaction
176. Molecular cloning of the rat intestinal trefoil factor gene
177. Ultrastructural co-localization of TFF3-peptide and oxytocin in the neural lobe of the porcine pituitary
178. Differential behavioral effects of TFF peptides: Injections of synthetic TFF3 into the rat amygdala
179. Characterization of the genomic structure and the promoter region of the human intestinal trefoil factor
180. The three human trefoil genes TFF1, TFF2, and TFF3 are located within a region of 55 kb on chromosome 21q22.3
181. Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in the gastric juice
182. Nucleosome positioning and transcription-associated chromatin alterations on the human estrogen-responsive pS2 promoter
183. The pathogenesis of duodenal gastric metaplasia: The role of local goblet cell transformation
184. Mechanisms for rapid reepithelialization of the gastric mucosal surface
185. Tracing the evolutionary origin of the TFF-domain, an ancient motif at mucous surfaces
186. Identification and characterization of rat intestinal trefoil factor: Tissue- and cell-specific member of the trefoil protein family
187. Intestinal trefoil factor binds to intestinal epithelial cells and induces nitric oxide production: Priming and enhancing effects of mucin
188. Prostanoids mediate the protective effect of trefoil factor 3 in oxidant-induced intestinal epithelial cell injury: Role of cyclooxygenase-2
189. Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro
190. The trefoil peptides spasmolytic polypeptide and intestinal trefoil factor are major secretory products of the rat gut
191. Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence
192. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor-and MAP kinase-dependent interregulation
193. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis
194. Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium
195. Characterization of the mouse TFF1 (pS2) gene promoter region
196. A new family of growth factor-like peptides: "Trefoil" disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins)
197. Isolation and characterization of putative trefoil peptide receptors
198. Pancreatic spasmolytic polypeptide (PSP): II. Radioimmunological determination of PSP in procine tissues, plasma and pancreatic juice
199. The amino acid sequence of pancreatic spasmolytic polypeptide
200. Characterization of human and rat intestinal trefoil factor produced in yeast
201. The bovine pancreatic spasmolytic polypeptide gene maps to syntenic group U10: Implications for the evolution of the human breast cancer estrogen inducible locus
202. hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma
203. The gene encoding the human spasmolytic protein (SML1/hSP) is in 21q22.3, physically linked to the homologous breast cancer marker gene BCEI/pS2
204. Identification and characterization of a novel gastric peptide hormone: The motilin-related peptide
205. pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins
206. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes
207. Short-chain fatty acids inhibit intestinal trefoil factor gene expression in colon cancer cells
208. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis
209. Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo
210. Goblet cells secretion and mucogenesis
211. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: Comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells
212. Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma
213. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: Identification of glycoforms and C-terminal cleavage
214. Localization of TFF3, a new mucus-associated peptide of the human respiratory tract
215. Synthesis and localization of the mucin-associated TFF-peptides in the human uterus
216. Trefoil factor family domain peptides
217. The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1
218. pS2 transfection of murine adenocarcinoma cell line 410.4 enhances dispersed growth pattern in a 3-D collagen gel
219. Short-chain fatty acids promote the migration of colonic epithelial cells in vitro
220. Peptide gene expression in gastrointestinal mucosal ulceration: Ordered sequence or redundancy
221. Aspects of the biology of regeneration and repair in the human gastrointestinal tract
222. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells
223. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues
224. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease
225. Rolling in the clover: Trefoil factor family (TFF)-domain peptides, cell migration and cancer